LICR MELBOURNE-AUSTIN BRANCH SEARCH
spacer
logo banner banner
spacer
Home LICR Melbourne-Austin Branch About Us research Clincial Trials Resources Students Careers Blank
Melbourne-Austin Branch News

Ludwig Institute’s Jonathan Cebon awarded Grant by Melanoma Research Alliance to help advance treatment and cure for skin disease that is fastest growing cancer

Ludwig Institute for Cancer Research, Melbourne-Austin Branch (LICR) proudly announced today that Director Medical Oncology Unit Professor Jonathan Cebon has been awarded an ‘Established Investigator Award’ and research grant by the Melanoma Research Alliance (MRA). MRA has awarded 22 researchers at leading academic research institutions around the world to develop improved means to prevent, detect and treat deadly skin cancer.

icon DOWNLOAD PRESS RELEASE

Other News

icon Official opening of the ANSTO/Austin/LICR Cyclotron Facility
icon Ludwig Institute For Cancer Research’s Discovery Leads To Australian Patient Trials
icon Cure Cancer Australia Foundation funds melanoma targeting project
icon LICR receives funding from Cancer Australia and Cancer Council Victoria 2011
icon Ludwig Institute For Cancer Research To Establish Worldclass Imaging Research Centre

Recent Publications

Hensley, S.E., Zanker, D., Dolan, B.P., David, A., Hickman, H.D., Embry, A.C., Skon, C.N., Grebe, K.M., Griffin, T.A., Chen, W., Bennink, J.R., and Yewdell, J.W., Unexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses. J Immunol, 2010. 184(8): p. 4115-22.

Keech, C.L., Pang, K.C., McCluskey, J., and Chen, W., Direct antigen presentation by DC shapes the functional CD8(+) T-cell repertoire against the nuclear self-antigen La-SSB. Eur J Immunol, 2010. 40(2): p. 330-8.

Lawrentschuk, N., Davis, I.D., Bolton, D.M., and Scott, A.M., Functional imaging of renal cell carcinoma. Nat Rev Urol, 2010. 7(5): p. 258-66.

Lee, F.T., O'Keefe, G.J., Gan, H.K., Mountain, A.J., Jones, G.R., Saunder, T.H., Sagona, J., Rigopoulos, A., Smyth, F.E., Johns, T.G., Govindan, S.V., Goldenberg, D.M., Old, L.J., and Scott, A.M., Immuno-PET Quantitation of de2-7 Epidermal Growth Factor Receptor Expression in Glioma Using 124I-IMP-R4-Labeled Antibody ch806. J Nucl Med, 2010. 51(6): p. 967-72.

Risbridger, G.P., Davis, I.D., Birrell, S.N., and Tilley, W.D., Breast and prostate cancer: more similar than different. Nat Rev Cancer, 2010. 10(3): p. 205-12.

Robson, N.C., McAlpine, T., Knights, A.J., Schnurr, M., Shin, A., Chen, W., Maraskovsky, E., and Cebon, J., Processing and cross presentation of individual HLA-A, -B or -C epitopes from NY-ESO-1 or a HLA-A epitope for Melan-A differ according to the mode of antigen delivery. Blood, Published online Apr 29 2010.

Sternberg, C.N., Davis, I.D., Mardiak, J., Szczylik, C., Lee, E., Wagstaff, J., Barrios, C.H., Salman, P., Gladkov, O.A., Kavina, A., Zarba, J.J., Chen, M., McCann, L., Pandite, L., Roychowdhury, D.F., and Hawkins, R.E., Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial. J Clin Oncol, 2010. 28(6): p. 1061-8.

Wilson, A.J., Chueh, A.C., Togel, L., Corner, G.A., Ahmed, N., Goel, S., Byun, D.S., Nasser, S., Houston, M.A., Jhawer, M., Smartt, H.J., Murray, L.B., Nicholas, C., Heerdt, B.G., Arango, D., Augenlicht, L.H., and Mariadason, J.M., Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction. Cancer Res, 2010. 70(2): p. 609-20

Publications Search
Resources Links
icon News
icon Publications

contact us

spacer
More Links
icon Victorian Cancer Agency
icon Cancer Council of Australia
icon Cancer Trials Australia
icon Austin Health
icon Olivia Newton-John Cancer Centre
icon Cancer Net
icon Cancer Research Institute
icon National Cancer Institute
icon ClinicalTrials.gov
spacer
Seminars

Seminars are held Mondays at 12:00pm at the Level 8 Lecture Theatre, Lance Townsend Building, Austin Hospital

Click here to view the current schedule

LICR